Falco Holdings Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Falco Holdings Co Ltd with three other
pharmaceutical manufacturers in Asia:
Dr. Lal PathLabs Ltd
sales of 10.57 billion Indian Rupees [US$153.46 million]
of which 100%
Thyrocare Technologies Ltd
(3.56 billion Indian Rupees [US$51.74 million]
Medical & Biological Laboratories Company Limited
(7.07 billion Japanese Yen [US$63.79 million]
of which 99%
was Reagent business).
Falco Holdings Co Ltd reported sales of ¥45.96 billion (US$414.58 million)
March of 2018.
decrease of 0.0%
versus 2017, when the company's sales were ¥45.97 billion.
Contributing to the drop in overall sales was the 0.3% decline
in Medical Test, from ¥27.85 billion to ¥27.77 billion.
However, these declines were partially offset by the increase in sales of
Preparation of Drugs (up 0.4% to ¥18.19 billion)